Home
>
National Drug Code (NDC)
>
Irinotecan Hydrochloride
Irinotecan Hydrochloride - 0703-4432-11 - (Irinotecan Hydrochloride)
Drug Information of Irinotecan Hydrochloride
| Product NDC: | 0703-4432 |
| Proprietary Name: | Irinotecan Hydrochloride |
| Non Proprietary Name: | Irinotecan Hydrochloride |
| Active Ingredient(s): | 40 mg/2mL & nbsp; Irinotecan Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Irinotecan Hydrochloride
| Product NDC: | 0703-4432 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090101 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080228 |
Package Information of Irinotecan Hydrochloride
| Package NDC: | 0703-4432-11 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4432-11) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Irinotecan Hydrochloride
| NDC Code | 0703-4432-11 |
| Proprietary Name | Irinotecan Hydrochloride |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4432-11) > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0703-4432 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Irinotecan Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080228 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | IRINOTECAN HYDROCHLORIDE |
| Strength Number | 40 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
